From news.search.yahoo.com via
Yahoo News.
()
 |
Invalid News Story. |
CEO Peter Dolan
CEO Peter Dolan has been the chief executive officer of Bristol-Myers Squibb Co since 2001. He is 50 years old. Follow Mr. Dolan and Bristol-Myers Squibb Co in the news and blogs or share your own opinion about the company and its... [more]
CEO Peter Dolan has been the chief executive officer of Bristol-Myers Squibb Co since 2001. He is 50 years old. Follow Mr. Dolan and Bristol-Myers Squibb Co in the news and blogs or share your own opinion about the company and its leadership.
News
Showing:
Top Stories
-
Archive
CHICAGO----Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
- Make A Date With Bristol-Myers Squibb (rss.topix.net)
- Bristol-Myers Squibb Foundation to Award $1.4 Million in Grants to ... (news.google.com)
Deutsche Bank analyst Barbara Ryan left pharma pholks with an interesting wishbone to chew on prior to Thanksgiving - the notion that large pharma was overdue for consolidation and that Pfizer ought to consider ...
More perspectives...
From rss.topix.net via
Topix.
()
Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.
More perspectives...
From medicalnewstoday.com
()
In a note late Tuesday, analyst Barbara Ryan envisioned scenarios where Pfizer Inc. might buy Amgen Inc., Bristol-Myers Squibb Co. or Wyeth, ...
More perspectives...
From news.google.com via
Google News.
()
Exelixis Inc. landed a $20 million milestone payment from Bristol-Myers Squibb Co. after the drug giant opted to co-develop and commercialize one of the ...
More perspectives...
From news.google.com via
Google News.
()
Exelixis Inc. landed a $20 million milestone payment from Bristol-Myers Squibb Co.
More perspectives...
Midland, MI - Dow Wolff Cellulosics, a business unit of The Dow Chemical Company and its affiliates, today announced that a second drug candidate developed by Bristol-Myers Squibb Company (NYSE: BMY) ... [WebWire - Thursday, November 20, 2008]
More perspectives...
From webwire.com
()
The National Comprehensive Cancer Network was awarded a $1.5 million grant from Bristol-Myers Squibb Co. and ImClone Systems Inc. to fund research on the ...
More perspectives...
From news.google.com via
Google News.
()
AP , 11.24.08, 07:25 AM EST Exelixis Inc. said Monday it will receive a $20 million milestone payment now that Bristol-Myers Squibb Co. has decided to ...
More perspectives...
From news.google.com via
Google News.
()
Exelixis, Inc. today announced that Bristol-Myers Squibb Company has exercised its option to develop and commercialize Exelixis' investigational new drug candidate XL413, a selective inhibitor of Cdc7.
More perspectives...
Big Pharmas are cutting costs; Bristol-Myers Squibb Co., Wyeth, Pfizer, Merck & Co., Schering-Plough Corp. and GlaxoSmithKline plc have all announced ...
More perspectives...
From news.google.com via
Google News.
()
Sales of top revenue contributor Plavix (used to treat coronary disease) grew by 15%, while sales of Abilify (an anti-depressant) were up 34%. ...
From news.google.com via
Google News.
()
- Bristol-Myers Squibb cancer drug rejected (rss.topix.net)
Bristol-Myers Squibb made a presentation this morning at the Credit Suisse Healthcare Conference that showed CFO John Marc-Huet wants to save the company $2.5 billion in "productivity initiatives." He's going ...
More perspectives...
From rss.topix.net via
Topix.
()
Drugmaker Bristol-Myers Squibb Co. thinks it can improve its cash flow by $750 million to $1 billion cumulatively by 2011, its chief financial officer said at a conference Thursday.
More perspectives...
From rss.topix.net via
Topix.
()
BOSTON (Reuters) - Bristol-Myers Squibb Co (BMY.N: Quote, Profile, Research, Stock Buzz) is taking steps to strengthen its balance sheet by as much as $1 ...
More perspectives...
From news.google.com via
Google News.
()
You can improve this news page by changing its keywords and content sources.
Edit News
Edit News
People in Pictures
Top Money Articles
 |
What Obama May Mean for Stocks
Barack Obama won the election in a landslide. Now what can we expect from Wallstreet?
|
 |
The Real Estate Effects of the Wall Street Mess
Wallstreet may be sitting on top of a billions bailout, but that won't exactly help you pay the mortgage!
|
 |
Sony Chases Apple's Magic
Suburban hipsters have adopted Apple as one of their own. How can Sony makes its way into the love-fest?
|
Popular Money Zines
